Here's What You May Have Missed About Synopsys (SNPS)

Shares of Technology sector company Synopsys moved 0.4% today, and are now trading at a price of $536.83. The large-cap stock's daily volume was 86,873 compared to its average volume of 778,020. The S&P 500 index returned a 0.0% performance.

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company is based in Mountain View and has 19,000 full time employees. Its market capitalization is $81,643,257,856.

14 analysts are following Synopsys and have set target prices ranging from $420.0 to $600.0 per share. On average, they have given the company a rating of buy. At today's prices, SNPS is trading 4.69% away from its average analyst target price of $512.79 per share.

Over the last year, SNPS's share price has increased by 65.0%, which represents a difference of 50.0% when compared to the S&P 500. The stock's 52 week high is $541.84 per share whereas its 52 week low is $312.25. With average free cash flows of $1.06 Billion that have been growing at an average rate of 30.4% over the last 6 years, Synopsys is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,770,718 170,175 1,600,543 -0.11
2022 1,738,900 136,589 1,602,311 14.54
2021 1,492,622 93,764 1,398,858 67.21
2020 991,313 154,717 836,596 38.88
2019 800,513 198,129 602,384 85.2
2018 424,232 98,976 325,256
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.